Nidhi Kadakia

Dr. Nidhi Kadakia

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2026 in Sage Open Pediatrics
Verified
Journal Article
Open access
NKNidhi Kadakia
Nidhi Kadakia
SASiraj Amanullah
Siraj Amanullah
AGAnnie Gjelsvik
Annie Gjelsvik
GMGazi Md. Salahuddin Mamun
Gazi Md. Salahuddin Mamun
SSShamsun Nahar Shaima
Shamsun Nahar Shaima
SGStephanie Chow Garbern
Stephanie Chow Garbern
Background/Objective: Pediatric sepsis remains a leading cause of child mortality worldwide. Early risk stratification using organ dysfunction scores may improve management. Bangladesh bears a high burden of pediatric infectious disease and sepsis, particularly in children under 5. This study compared the predictive performance of admission PELOD-2, pSOFA, and Phoenix Sepsis Scores for in-hospital mortality among pediatric sepsis patients. Methods: We conducted a secondary analysis of an observational study at a tertiary hospital in Dhaka, Bangladesh (February-December 2022). Of 100 enrolled children aged 2 months to 18 years with sepsis, 96 had sufficient data for score calculation. Results: Median age was 8 months (IQR 5-18), and in-hospital mortality was 23%. Admission PELOD-2 >3 and pSOFA >6 were associated with increased mortality. AUCs for mortality were 0.83 (pSOFA), 0.82 (PELOD-2), and 0.79 (Phoenix). Conclusions: All 3 scores showed good mortality discrimination. pSOFA and Phoenix may be more feasible in low-resource settings.

3 July 2026 in Pediatric Reports
Verified
Journal Article
Open access
PDF file
Kaden BunchKaden Bunch
Kaden Bunch
SSShamsun Nahar Shaima
Shamsun Nahar Shaima
GMGazi Md. Salahuddin Mamun
Gazi Md. Salahuddin Mamun
SJSai Gopal Jarabana
Sai Gopal Jarabana
MGMonique Gainey
Monique Gainey
SGStephanie Chow Garbern
Stephanie Chow Garbern
Background: Sepsis is a leading cause of pediatric mortality worldwide, disproportionately affecting children in low- and middle-income countries (LMICs). However, timely recognition of potential sepsis and access to healthcare resources needed to diagnose pediatric sepsis according to international guidelines are challenging in LMICs. This exploratory study aimed to develop machine learning (ML) models to detect pediatric sepsis and septic shock using a simplified set of clinical data contextualized for practical use in resource-limited settings. Methods: This was a secondary analysis of an observational study of 100 children with potential sepsis admitted to a non-profit referral hospital in Dhaka, Bangladesh. The outcomes were sepsis as defined by a Phoenix Sepsis Score (PSS) ≥ 2 and septic shock (sepsis plus PSS cardiovascular sub-score ≥ 1). Models were trained using either clinical + laboratory variables or clinical-only variables. A single 24 h worst-value assessment window was derived per patient; stratified 5-fold cross-validation was used to maintain class proportions across the training and test folds. Model performance was assessed using area under the precision–recall curve (AUPRC) and area under the receiver operating characteristic curve (AUROC) with 95% confidence intervals (CIs) derived from a 2000-resample patient-level bootstrap of out-of-fold classifications. Logistic regression coefficients were used to assess feature contributions. Results: For sepsis classification, the non-laboratory model achieved an AUPRC of 0.942 (95% CI: 0.884–0.979) and an AUROC of 0.945 (95% CI: 0.890–0.983), with comparable performance from the clinical + laboratory model (AUPRC 0.941, 95% CI: 0.880–0.981; AUROC 0.945, 95% CI: 0.881–0.986). For septic shock, AUROCs of 0.870 (95% CI: 0.761–0.952) and 0.878 (95% CI: 0.758–0.967) were observed. However, these estimates should be interpreted cautiously, given the low prevalence (23%) and absence of external validation. SpO2:FiO2 ratio, GCS, and systolic blood pressure were consistently strong predictors across models. Conclusions: ML models using pragmatic clinical variables demonstrate preliminary diagnostic performance, with the non-laboratory model showing discrimination comparable to models incorporating laboratory data. Logistic regression demonstrated the most stable performance and may represent an early proof of concept for assistive diagnostic support. However, these models are not clinically usable without external validation. These findings are hypothesis-generating; external validation in larger, independent cohorts is essential before any clinical use, particularly for septic shock.

13 March 2025 in JMIR Preprints
Verified
Preprint
Open access
SSShamsun Nahar Shaima
Shamsun Nahar Shaima
AGAlicia E Genisca
Alicia E Genisca
Md Tanveer FarukMd Tanveer Faruk
Md Tanveer Faruk
MUMd. Fakhar Uddin
Md. Fakhar Uddin
ASAkash Saha
Akash Saha
SGStephanie Chow Garbern
Stephanie Chow Garbern
BACKGROUND Sepsis, a life-threatening condition resulting from a dysregulated immune response to infection, disproportionately affects children in low- and middle-income countries (LMICs). Children with sepsis in LMICs face high mortality rates, with early detection and clinical monitoring posing significant challenges to effective management. There is great potential for digital technologies, such as wearable biosensor devices and mobile health (mHealth) clinical decision support (CDS) tools, together referred to as clinical decision support systems (CDSSs), to enable closer monitoring and more prompt recognition of children at risk of advanced sepsis and death. However, little is known about the perceptions of health care providers (HCPs) regarding the introduction of new digital health tools for pediatric sepsis care in LMICs. OBJECTIVE The objective of this study was to assess HCPs’ understanding, perceptions, and recommendations regarding the design and implementation of digital CDSSs for pediatric sepsis care in Bangladesh. METHODS Between February and May 2024, 18 individual semistructured in-depth interviews were conducted with HCPs (nurses and physicians) at 3 urban hospitals in Bangladesh. The data were transcribed, translated from Bangla to English, and analyzed using a framework matrix analysis approach. Participants were asked about familiarity with digital health tools, feedback on CDSS design, perceptions of the system’s utility, and barriers and facilitators to use of similar tools in clinical settings in Bangladesh. RESULTS Participants reported overall positive perceptions toward the potential implementation of a CDSS for pediatric sepsis care in Bangladesh. Some key priorities for the design of a CDSS were durability, reusability, cost considerations, reliability, and accuracy. Clinicians desired the CDS tool to also have customizable alarm parameters and include additional functions such as glucose monitoring. Many favored audio (ringtone) or visual (light) alarms to alert about changes in captured vital signs. HCPs believed that a CDSS could enhance patient care by allowing greater staff capacity to monitor patients, reducing management time, and aiding in faster clinical decision-making, with some suggesting it could lower mortality rates. Concerns regarding implementation included internet availability, affordability of the wearable devices, and trust in the CDSS outputs compared to expert clinician judgement. CONCLUSIONS The findings of this study highlight HCPs’ perceptions toward the potential of wearable biosensor devices and CDS tools (CDSSs) for improving pediatric sepsis outcomes in LMICs and highlight the need to address implementation challenges to ensure the effective integration of CDSSs into health care systems.

26 September 2025 in JMIR Formative Research
Verified
Journal Article
Open access
SSShamsun Nahar Shaima
Shamsun Nahar Shaima
AGAlicia E Genisca
Alicia E Genisca
Md Tanveer FarukMd Tanveer Faruk
Md Tanveer Faruk
MUMd. Fakhar Uddin
Md. Fakhar Uddin
ASAkash Saha
Akash Saha
SGStephanie Chow Garbern
Stephanie Chow Garbern
Background: Sepsis, a life-threatening condition resulting from a dysregulated immune response to infection, disproportionately affects children in low- and middle-income countries (LMICs). Children with sepsis in LMICs face high mortality rates, with early detection and clinical monitoring posing significant challenges to effective management. There is great potential for digital technologies, such as wearable biosensor devices and mobile health (mHealth) clinical decision support (CDS) tools, together referred to as clinical decision support systems (CDSSs), to enable closer monitoring and more prompt recognition of children at risk of advanced sepsis and death. However, little is known about the perceptions of health care providers (HCPs) regarding the introduction of new digital health tools for pediatric sepsis care in LMICs. Objective: The objective of this study was to assess HCPs’ understanding, perceptions, and recommendations regarding the design and implementation of digital CDSSs for pediatric sepsis care in Bangladesh. Methods: Between February and May 2024, 18 individual semistructured in-depth interviews were conducted with HCPs (nurses and physicians) at 3 urban hospitals in Bangladesh. The data were transcribed, translated from Bangla to English, and analyzed using a framework matrix analysis approach. Participants were asked about familiarity with digital health tools, feedback on CDSS design, perceptions of the system’s utility, and barriers and facilitators to use of similar tools in clinical settings in Bangladesh. Results: Participants reported overall positive perceptions toward the potential implementation of a CDSS for pediatric sepsis care in Bangladesh. Some key priorities for the design of a CDSS were durability, reusability, cost considerations, reliability, and accuracy. Clinicians desired the CDS tool to also have customizable alarm parameters and include additional functions such as glucose monitoring. Many favored audio (ringtone) or visual (light) alarms to alert about changes in captured vital signs. HCPs believed that a CDSS could enhance patient care by allowing greater staff capacity to monitor patients, reducing management time, and aiding in faster clinical decision-making, with some suggesting it could lower mortality rates. Concerns regarding implementation included internet availability, affordability of the wearable devices, and trust in the CDSS outputs compared to expert clinician judgement. Conclusions: The findings of this study highlight HCPs’ perceptions toward the potential of wearable biosensor devices and CDS tools (CDSSs) for improving pediatric sepsis outcomes in LMICs and highlight the need to address implementation challenges to ensure the effective integration of CDSSs into health care systems.